A new ICD-10 Clinical Modification (ICD-10-CM) code set took effect October 1, 2023.  In this new code set, there are changes that may relate to the care of wounds using surgical dressings. Below is a list of some of the more pertinent changes.

D48.1 (Neoplasm of uncertain behavior of connective and other soft tissue)

Prior to 10-1-23, D48.1 (Neoplasm of uncertain behavior of connective and other soft tissue) was a complete ICD-10 code.  Starting 10-1-23, D48.1 is no longer a complete ICD-10 code and requires additional characters.

The new code options are:

  • D48.11 Desmoid tumor
  • D48.110 Desmoid tumor of head and neck
  • D48.111 Desmoid tumor of chest wall
  • D48.112 Desmoid tumor, intrathoracic
  • D48.113 Desmoid tumor of abdominal wall
  • D48.114 Desmoid tumor, intra-abdominal
  • D48.115 Desmoid tumor of upper extremity and shoulder girdle
  • D48.116 Desmoid tumor of lower extremity and pelvic girdle
  • D48.117 Desmoid tumor of back
  • D48.118 Desmoid tumor of other site
  • D48.119 Desmoid tumor of unspecified site
  • D48.19 Other specified neoplasm of uncertain behavior of connective and other soft tissue

D57 Sickle-cell codes

Throughout all of the D57 Sickle-cell codes “vasoocclusive” changed to “vaso-occlusive”.

E20.8 (Other hypoparathyroidism)

Prior to 10-1-23,  E20.8 (Other hypoparathyroidism) was a complete ICD-10 code.  Starting 10-1-23, E20.8 is no longer a complete ICD-10 code and requires additional characters.

The new code options are:

  • E20.81 Hypoparathyroidism due to impaired parathyroid hormone secretion
  • E20.810 Autosomal dominant hypocalcemia
  • E20.811 Secondary hypoparathyroidism diseases classified elsewhere
  • E20.812 Autoimmune hypoparathyroidism
  • E20.818 Other specified hypoparathyroidism due to impaired parathyroid hormone secretion
  • E20.819 Hypoparathyroidism due to impaired parathyroid hormone secretion, unspecified
  • E20.89 Other specified hypoparathyroidism

I87.2 Venous insufficiency (chronic) (peripheral)

I87.2 Venous insufficiency (chronic) (peripheral) carries a new instruction to, “Use additional code, if applicable, to specify site and severity of ulcer (L97.-)”

G20 (Parkinson’s disease)

Prior to 10-1-23, G20 (Parkinson’s disease) was a complete ICD-10 code. Starting 10-1-23, G20- is no longer a complete ICD-10 code and requires additional characters.

The new code options are:

  • G20.A Parkinson’s disease without dyskinesia
  • G20.A1 Parkinson’s disease without dyskinesia, without mention of fluctuations
  • G20.A2 Parkinson’s disease without dyskinesia, with fluctuations
  • G20.B Parkinson’s disease with dyskinesia
  • G20.B1 Parkinson’s disease with dyskinesia, without mention of fluctuations
  • G20.B2 Parkinson’s disease with dyskinesia, with fluctuations
  • G20.C Parkinsonism, unspecified

New ICD-10-CM codes

The following are new ICD-10-CM codes:

  • Z16.13 Resistance to carbapenem
  • Z22.34 Carrier of Acinetobacter baumannii
  • Z22.340 Carrier of carbapenem-resistant Acinetobacter baumannii       
  • Z22.341 Carrier of carbapenem-sensitive Acinetobacter baumannii       
  • Z22.349 Carrier of Acinetobacter baumannii, unspecified
  • Z22.35 Carrier of Enterobacterales
  • Z22.350 Carrier of carbapenem-resistant Enterobacterales
  • Z22.358 Carrier of other Enterobacterales
  • Z22.359 Carrier of Enterobacterales, unspecified

Conclusion

These changes became effective October 1, 2023, and all providers of all types should be using the new ICD-10-CM code set now.

References

Dr. Jeffrey D. Lehrman, DPM, FASPS, MAPWCA, CPC
Dr. Jeffrey D. Lehrman, DPM, FASPS, MAPWCA, CPC, CPMA
Read more from Dr. Lehrman

Dr. Lehrman is a podiatrist practicing in Fort Collins, CO and operates Lehrman Consulting, LLC which provides consultation services regarding coding, compliance and documentation. Dr. Lehrman is a Certified Professional Coder and Certified Professional Medical Auditor. He serves as a staff liaison at the AMA CPT® Editorial Panel meetings where CPT codes are created, edited, and deleted. He is a Diplomate of the American Board of Foot and Ankle Surgery, Fellow of the American Society of Podiatric Surgeons, and is recognized as a “Master” by the American Professional Wound Care Association. Dr Lehrman is a Fellow of the American Academy of Podiatric Practice Management, Past Director of the American Professional Wound Care Association Board of Directors, and is a Past Chairman of the Board of the American Society of Podiatric Surgeons. Dr. Lehrman is also on the editorial advisory board of the journal WOUNDS.